Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.46 |
| ▸ | CES2 | O00748 | 3/20 | 0.46 |
| ▸ | CES1 | P23141 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL596041 | 0.88 | ALDH1A1 (0.78) | ALDH1A1ALOX15KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL11586104 | 0.86 | ALDH1A1 (0.58) | ALDH1A1ALOX15TSHRKDM4EHPGD | |
| SCHEMBL409296 | 0.82 | KDM4E (0.64) | ALDH1A1ALOX15TSHRKDM4EHPGD | |
| SCHEMBL9856654 | 0.82 | ALDH1A1 (0.46) | ALDH1A1ALOX15TSHRKDM4ECES2 | |
| SCHEMBL891523 | 0.82 | AKR1C3 (0.71) | ALDH1A1KDM4ESMN1; SMN2MAPTHSD17B10 | |
| SCHEMBL6972335 | 0.80 | TSHR (0.63) | ALDH1A1ALOX15TSHRKDM4ECA1 | |
| SCHEMBL4166060 | 0.80 | CES2 (0.64) | ALDH1A1ALOX15TSHRCES2CES1 | |
| SCHEMBL16470694 | 0.80 | ELANE (0.41) | ALDH1A1ALOX15TSHRKDM4ESMN1; SMN2 | |
| SCHEMBL3806095 | 0.80 | MAPT (0.58) | ALDH1A1ALOX15TSHRKDM4EHPGD | |
| SCHEMBL2165280 | 0.80 | MEN1 (0.52) | ALDH1A1ALOX15TSHRKDM4ECES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2669342-B1 | ACTIVE-ENERGY-RAY-CURABLE INKJET INK COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE INKJET INK, AND INKJET RECORDING METHOD | KONICA MINOLTA INC (JP) | 2020-03-18 | — | — | EP | disclosed |
| EP-2584011-B1 | INKJET INK AND INKJET IMAGE FORMATION METHOD USING SAME | KONICA MINOLTA HOLDINGS INC (JP) | 2018-06-20 | — | — | EP | disclosed |
| US-9416289-B2 | Active-energy-ray-curable inkjet ink composition, active-energy-ray-curable inkjet ink, and inkjet recording method | Konica Minolta, Inc. (JP) | 2016-08-16 | — | — | US | disclosed |
| US-9175180-B2 | Inkjet ink and inkjet image formation method using same | Konica Minolta, Inc. (JP) | 2015-11-03 | — | — | US | disclosed |
| EP-2669342-A1 | ACTIVE-ENERGY-RAY-CURABLE INKJET INK COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE INKJET INK, AND INKJET RECORDING METHOD | Konica Minolta, Inc. (JP) | 2013-12-04 | — | — | EP | disclosed |
| US-20130307913-A1 | ACTIVE-ENERGY-RAY-CURABLE INKJET INK COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE INKJET INK, AND INKJET RECORDING METHOD | Konica Minolta, Inc. (JP) | 2013-11-21 | — | — | US | disclosed |
| EP-2584011-A1 | INKJET INK AND INKJET IMAGE FORMATION METHOD USING SAME | Konica Minolta Holdings, Inc. (JP) | 2013-04-24 | — | — | EP | disclosed |
| US-20130095236-A1 | INKJET INK AND INKJET IMAGE FORMATION METHOD USING SAME | KONICA MINOLTA HOLDINGS, INC. (JP) | 2013-04-18 | — | — | US | disclosed |
| EP-1652834-B1 | Process for producing salicylic esters | KAO CORP (JP) | 2008-10-01 | — | — | EP | disclosed |
| EP-1652834-A1 | Process for producing salicylic esters | KAO CORPORATION (JP) | 2006-05-03 | — | — | EP | disclosed |
| US-20060058547-A1 | Process for producing salicylic esters | KAO CORPORATION (JP) | 2006-03-16 | — | — | US | disclosed |
| EP-1634571-A1 | Transesterification process for producing salicylic esters used in perfumes | KAO CORPORATION (JP) | 2006-03-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060058547-A1 | Process for producing salicylic esters | NOTUM, FASN, AGPS | ALDH1A1 268/4885ALOX15 23/4885TSHR 3808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.